These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2081228)

  • 1. Cyclosporin nephrotoxicity.
    Neild GH
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):198-203. PubMed ID: 2081228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A.
    Dische FE; Neuberger J; Keating J; Parsons V; Calne RY; Williams R
    Lab Invest; 1988 Apr; 58(4):395-402. PubMed ID: 3282124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with cyclosporin/prednisolone therapy in kidney transplantation, with special reference to nephrotoxicity, ATN and kidney preservation.
    Pichlmayr R; Wonigeit K; Klempnauer J; Ringe B; Bunzendahl H; Kreller H; Heigel B; Siegismund S
    Neth J Med; 1985; 28(6):268-71. PubMed ID: 3892330
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnetic resonance imaging of renal transplants: its value in the differentiation of acute rejection and cyclosporin A nephrotoxicity.
    te Strake L; Schultze Kool LJ; Paul LC; Tegzess AM; Weening JJ; Hermans J; Doornbos J; Bluemm RG; Bloem JL
    Clin Radiol; 1988 May; 39(3):220-8. PubMed ID: 3293883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity.
    Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535
    [No Abstract]   [Full Text] [Related]  

  • 8. What is cyclosporine nephrotoxicity?
    Myers BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1430-2. PubMed ID: 2652460
    [No Abstract]   [Full Text] [Related]  

  • 9. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ; Benvenisty AI; Cianci J; Hardy MA
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief review of histopathology in kidney transplant recipients immunosuppressed with cyclosporin A.
    Mihatsch MJ
    Scand J Urol Nephrol Suppl; 1985; 92():95-7. PubMed ID: 3914070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.
    Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil ameliorates acute cyclosporine A (CsA) nephrotoxicity and improves immunosuppression after cadaver renal transplantation.
    Dawidson I; Rooth P; Fisher D; Fry WR; Alway C; Coorpender L; Reisch J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1511-3. PubMed ID: 2652487
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
    Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
    Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine use in early graft dysfunction.
    Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):104-12. PubMed ID: 3515675
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrarenal manometry in the diagnosis of acute rejection superimposed on acute tubular necrosis in renal transplantation.
    García R; Rodríguez-Iturbe B; Henríquez-La Roche C; Marín C; Mosquera J
    Clin Nephrol; 1989 Jul; 32(1):21-6. PubMed ID: 2667825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition, diagnosis, and management of rejection in the second to sixth months posttransplant--an overview.
    Matas AJ; Tellis VA; Quinn T; Soberman R; Veith FJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):141-50. PubMed ID: 3515682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-needle intrarenal manometry: a new test for rejection in cyclosporin-treated recipients of kidney transplants.
    Salaman JR; Griffin PJ
    Lancet; 1983 Sep; 2(8352):709-11. PubMed ID: 6136842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical renal transplantation: exfoliative urinary cytology in the evaluation of nephrotoxicity induced by cyclosporin therapy].
    Stella F; Alfani D; Renna Molajoni E; Rossi M; Rossi Lemeni A; Stella C; Di Tondo U; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1984 Sep; 20(3):295-303. PubMed ID: 6397762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.